Literature DB >> 10750094

Effect of Lactobacillus reuteri on the prevention of hypercholesterolemia in mice.

M P Taranto1, M Medici, G Perdigon, A P Ruiz Holgado, G F Valdez.   

Abstract

Administration of Lactobacillus reuteri CRL 1098 (10(4) cells/d) to mice for 7 d before inducing hypercholesterolemia (by feeding mice with a fat-enriched diet for the subsequent 7 d) was evaluated. At this low dose, L. reuteri was effective in preventing hypercholesterolemia in mice, producing a 17% increase in the ratio of high-density lipoprotein to low-density lipoprotein. Total cholesterol and triglycerides decreased by 22 and 33%, respectively, in the group that was not fed the lactobacilli. The hypocholesterolemic effect produced by L. reuteri CRL 1098 might be considered as indirect evidence of the permanency of the lactobacilli in the gut.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10750094     DOI: 10.3168/jds.S0022-0302(00)74895-8

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  23 in total

Review 1.  Bile salt hydrolase activity in probiotics.

Authors:  Máire Begley; Colin Hill; Cormac G M Gahan
Journal:  Appl Environ Microbiol       Date:  2006-03       Impact factor: 4.792

2.  Genes involved in obesity: Adipocytes, brain and microflora.

Authors:  L Macia; O Viltart; C Verwaerde; M Delacre; A Delanoye; C Grangette; I Wolowczuk
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

Review 3.  Role of gut microbiota in atherosclerosis.

Authors:  Annika Lindskog Jonsson; Fredrik Bäckhed
Journal:  Nat Rev Cardiol       Date:  2016-12-01       Impact factor: 32.419

Review 4.  Probiotics and Disease: A Comprehensive Summary-Part 3, Cardiometabolic Disease and Fatigue Syndromes.

Authors:  Christy B Williamson; Cathleen M Burns; Crystal M Gossard; Jessica M Pizano; Keren E Dolan; Heather J Finley; Margaret G Gasta; Emily C Parker; Elizabeth A Lipski
Journal:  Integr Med (Encinitas)       Date:  2017-02

5.  Effects of four Bifidobacteria on obesity in high-fat diet induced rats.

Authors:  Ya-Ni Yin; Qiong-Fen Yu; Nian Fu; Xiao-Wei Liu; Fang-Gen Lu
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

Review 6.  Probiotics and medical nutrition therapy.

Authors:  Amy C Brown; Ana Valiere
Journal:  Nutr Clin Care       Date:  2004 Apr-Jun

Review 7.  Potential uses of probiotics in clinical practice.

Authors:  Gregor Reid; Jana Jass; M Tom Sebulsky; John K McCormick
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

8.  Lactobacillus reuteri CRL1098 produces cobalamin.

Authors:  María P Taranto; José L Vera; Jeroen Hugenholtz; Graciela F De Valdez; Fernando Sesma
Journal:  J Bacteriol       Date:  2003-09       Impact factor: 3.490

Review 9.  Perspective: Practical Approach to Preventing Subclinical B12 Deficiency in Elderly Population.

Authors:  Alessandra Vincenti; Laura Bertuzzo; Antonio Limitone; Giuseppe D'Antona; Hellas Cena
Journal:  Nutrients       Date:  2021-06-02       Impact factor: 5.717

Review 10.  Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases.

Authors:  Manoj Kumar; Ravinder Nagpal; Rajesh Kumar; R Hemalatha; Vinod Verma; Ashok Kumar; Chaitali Chakraborty; Birbal Singh; Francesco Marotta; Shalini Jain; Hariom Yadav
Journal:  Exp Diabetes Res       Date:  2012-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.